Rasagiline in Participants Treated With Levodopa/Carbidopa Therapy

Study Title
Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.
Teva Identifier
TVP - 1012/135 Double Blind
ClinicalTrials.gov Identifier
NCT00203177
Study Status
Completed
Trial Condition(s)
Parkinson's Disease
Interventions
Drug: rasagiline mesylate | Drug: rasagiline mesylate 1.0 mg

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
30 Years and older
Trial Duration
10/01/2001 - 01/00/1900
Phase
Phase 3

Study Type

Interventional